NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

尿激酶市場調查報告:各類型,各用途-2025年前的預測-COVID-19累積的影響

Urokinase Market Research Report by Type (Urokinase Powder and Urokinase Solution), by Application (Clinic and Hospital), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1000971
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
尿激酶市場調查報告:各類型,各用途-2025年前的預測-COVID-19累積的影響 Urokinase Market Research Report by Type (Urokinase Powder and Urokinase Solution), by Application (Clinic and Hospital), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 190 Pages
簡介

全球尿激酶的市場規模預測將從2020年的22億7,709萬美元,達到2025年的26億9,700萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供尿激酶市場相關調查,提供市場概要,以及各類型,各用途,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各用途預測
  • 各類型預測
  • 各地區預測
  • 其他競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球尿激酶市場,各類型

  • 尿激酶粉末
  • 尿激酶溶液

第7章 全球尿激酶市場,各用途

  • 診療所
  • 醫院

第8章 南北美洲的尿激酶市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的尿激酶市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲的尿激酶市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • 4SC AG
  • Eumedica Pharmaceuticals
  • ImaRX Therapeutics
  • Jiangsu Aidea Pharmaceutica
  • Jiangxi Haoran Bio-Pharma
  • Livzon Pharmaceutical Factory of Livzon Group
  • Microbix Biosystems Inc.
  • Nanjing Nanda Pharmaceutical Co. Ltd.
  • NDPharm
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Shandong PKU High-tech Huatai Pharmaceutical Co. Ltd.
  • Syner-Med Pharmaceuticals
  • Taj Pharmaceuticals Ltd
  • Tianjin Biochemical Pharmaceutical Co. Ltd.
  • Wanhua Biochem
  • Wilex AG
  • Wuhan Humanwell Pharmaceutical Co. Ltd.
  • ZYDUS CADILA HEALTHCARE LTD.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-0355054AC507

The Global Urokinase Market size was estimated at USD 2,277.09 Million in 2020 and expected to reach USD 2,366.87 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.28% to reach USD 2,928.29 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Urokinase to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Urokinase Market was studied across Urokinase Powder and Urokinase Solution.

Based on Application, the Urokinase Market was studied across Clinic and Hospital.

Based on Geography, the Urokinase Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Urokinase Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Urokinase Market, including 4SC AG, Eumedica Pharmaceuticals, ImaRX Therapeutics, Jiangsu Aidea Pharmaceutica, Jiangxi Haoran Bio-Pharma, Livzon Pharmaceutical Factory of Livzon Group, Microbix Biosystems Inc., Nanjing Nanda Pharmaceutical Co. Ltd., NDPharm, Salvavidas Pharmaceutical Pvt. Ltd., Shandong PKU High-tech Huatai Pharmaceutical Co. Ltd., Syner-Med Pharmaceuticals, Taj Pharmaceuticals Ltd, Tianjin Biochemical Pharmaceutical Co. Ltd., Wanhua Biochem, Wilex AG, Wuhan Humanwell Pharmaceutical Co. Ltd., and ZYDUS CADILA HEALTHCARE LTD..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Urokinase Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urokinase Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urokinase Market?
  • 4. What is the competitive strategic window for opportunities in the Global Urokinase Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Urokinase Market?
  • 6. What is the market share of the leading vendors in the Global Urokinase Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Urokinase Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. Type Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of pulmonary embolism globally
      • 5.1.1.2. Usage of urokinase in the treatment of cardiovascular disease
      • 5.1.1.3. Growing instances of Intracerebral hemorrhage
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects caused by urokinase such as Urticaria, difficulty in breathing, and swelling of face, lips, tongue, or throat
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research activities for using urokinase in stroke patients
      • 5.1.3.2. Economic development and substantial infrastructure development
    • 5.1.4. Challenges
      • 5.1.4.1. Urokinase is contraindicated in patients suffering from cancer, brain tumor and high blood pressure
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Urokinase Market, by Type

  • 6.1. Introduction
  • 6.2. Urokinase Powder
  • 6.3. Urokinase Solution

7. Urokinase Market, by Application

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital

8. Americas Urokinase Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Urokinase Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Urokinase Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. 4SC AG
  • 12.2. Eumedica Pharmaceuticals
  • 12.3. ImaRX Therapeutics
  • 12.4. Jiangsu Aidea Pharmaceutica
  • 12.5. Jiangxi Haoran Bio-Pharma
  • 12.6. Livzon Pharmaceutical Factory of Livzon Group
  • 12.7. Microbix Biosystems Inc.
  • 12.8. Nanjing Nanda Pharmaceutical Co. Ltd.
  • 12.9. NDPharm
  • 12.10. Salvavidas Pharmaceutical Pvt. Ltd.
  • 12.11. Shandong PKU High-tech Huatai Pharmaceutical Co. Ltd.
  • 12.12. Syner-Med Pharmaceuticals
  • 12.13. Taj Pharmaceuticals Ltd
  • 12.14. Tianjin Biochemical Pharmaceutical Co. Ltd.
  • 12.15. Wanhua Biochem
  • 12.16. Wilex AG
  • 12.17. Wuhan Humanwell Pharmaceutical Co. Ltd.
  • 12.18. ZYDUS CADILA HEALTHCARE LTD.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROKINASE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL UROKINASE MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL UROKINASE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2026
  • FIGURE 10. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 15. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 17. GLOBAL UROKINASE MARKET SIZE, BY CLINIC, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL UROKINASE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 22. AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 24. ARGENTINA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 25. BRAZIL UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 26. CANADA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. MEXICO UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. UNITED STATES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. CALIFORNIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. FLORIDA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. ILLINOIS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. NEW YORK UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. OHIO UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. PENNSYLVANIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. TEXAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 37. ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 39. CHINA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. INDIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. INDONESIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. JAPAN UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. MALAYSIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. PHILIPPINES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. SOUTH KOREA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. THAILAND UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 48. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 50. FRANCE UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. GERMANY UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. ITALY UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. NETHERLANDS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. QATAR UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. RUSSIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. SAUDI ARABIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. SOUTH AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. SPAIN UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. UNITED KINGDOM UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. GLOBAL UROKINASE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 62. GLOBAL UROKINASE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 63. GLOBAL UROKINASE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL UROKINASE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL UROKINASE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL UROKINASE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. UNITED STATES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CALIFORNIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CALIFORNIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. FLORIDA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. FLORIDA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ILLINOIS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ILLINOIS UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. NEW YORK UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. NEW YORK UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. OHIO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. OHIO UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. PENNSYLVANIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. PENNSYLVANIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. TEXAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. TEXAS UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CHINA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. INDIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ITALY UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. QATAR UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. GLOBAL UROKINASE MARKET: SCORES
  • TABLE 82. GLOBAL UROKINASE MARKET: BUSINESS STRATEGY
  • TABLE 83. GLOBAL UROKINASE MARKET: PRODUCT SATISFACTION
  • TABLE 84. GLOBAL UROKINASE MARKET: RANKING
  • TABLE 85. GLOBAL UROKINASE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 86. GLOBAL UROKINASE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 87. GLOBAL UROKINASE MARKET: MERGER & ACQUISITION
  • TABLE 88. GLOBAL UROKINASE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 89. GLOBAL UROKINASE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 90. GLOBAL UROKINASE MARKET: INVESTMENT & FUNDING
  • TABLE 91. GLOBAL UROKINASE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 92. GLOBAL UROKINASE MARKET: LICENSE & PRICING
  • TABLE 93. GLOBAL UROKINASE MARKET: CONTACT DETAILS